Singapore, Singapore · Founded 2020 · Privately Held (backing)
Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. Nuevocor is based in Singapore, Singapore and was founded in 2020. Its last reported valuation was $30.1 million in Nov 2022. It has raised $80.6 million.
Last reported valuation
$30.1M
Oct 2026
Priced at
—
Total raised
$80.6M
Last round
—
Team — not yet on record
No current team members for Nuevocor are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nuevocor with a free account
·The complete investor list: 12 names
·Watch Nuevocor: the Monday email on marks, rounds and moves
